Performance of PI-RADS v2 assessment categories assigned prior to MR-US fusion biopsy in a new fusion biopsy program.

[1]  D. Margolis,et al.  Prostate Imaging Reporting and Data System Version 2.1: 2019 Update of Prostate Imaging Reporting and Data System Version 2. , 2019, European urology.

[2]  Prasad R. Shankar,et al.  A Systematic Review of the Existing Prostate Imaging Reporting and Data System Version 2 (PI-RADSv2) Literature and Subset Meta-Analysis of PI-RADSv2 Categories Stratified by Gleason Scores. , 2019, AJR. American journal of roentgenology.

[3]  D. Margolis,et al.  MRI‐Targeted or Standard Biopsy for Prostate‐Cancer Diagnosis , 2018, The New England journal of medicine.

[4]  A. Westphalen,et al.  PI-RADS v2 and ADC values: is there room for improvement? , 2018, Abdominal Radiology.

[5]  A. Becker,et al.  Direct comparison of PI-RADS version 2 and version 1 regarding interreader agreement and diagnostic accuracy for the detection of clinically significant prostate cancer. , 2017, European journal of radiology.

[6]  D. Margolis,et al.  Risk Stratification Among Men With Prostate Imaging Reporting and Data System version 2 Category 3 Transition Zone Lesions: Is Biopsy Always Necessary? , 2017, AJR. American journal of roentgenology.

[7]  Su-Jin Shin,et al.  PI-RADS Version 2: Detection of Clinically Significant Cancer in Patients With Biopsy Gleason Score 6 Prostate Cancer. , 2017, AJR. American journal of roentgenology.

[8]  James S. Babb,et al.  Proposed Adjustments to PI-RADS Version 2 Decision Rules: Impact on Prostate Cancer Detection. , 2017, Radiology.

[9]  M. Parmar,et al.  Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confi rmatory study , 2018 .

[10]  Baris Turkbey,et al.  Accuracy and agreement of PIRADSv2 for prostate cancer mpMRI: A multireader study , 2017, Journal of magnetic resonance imaging : JMRI.

[11]  T. Miyagawa,et al.  Combination of prostate imaging reporting and data system (PI‐RADS) score and prostate‐specific antigen (PSA) density predicts biopsy outcome in prostate biopsy naïve patients , 2017, BJU international.

[12]  G. Carvalhal,et al.  Validation of PI‐RADS v.2 for prostate cancer diagnosis with MRI at 3T using an external phased‐array coil , 2016, Journal of magnetic resonance imaging : JMRI.

[13]  P. Choyke,et al.  Prospective Evaluation of the Prostate Imaging Reporting and Data System Version 2 for Prostate Cancer Detection. , 2016, The Journal of urology.

[14]  Feiyu Li,et al.  The efficiency of multiparametric magnetic resonance imaging (mpMRI) using PI-RADS Version 2 in the diagnosis of clinically significant prostate cancer. , 2016, Clinical imaging.

[15]  A. Westphalen,et al.  Multiparametric MRI of the prostate: diagnostic performance and interreader agreement of two scoring systems. , 2016, The British journal of radiology.

[16]  Tobias Franiel,et al.  Assessment of PI-RADS v2 for the Detection of Prostate Cancer. , 2016, European journal of radiology.

[17]  Koon Ho Rha,et al.  Prostate Cancer: PI-RADS Version 2 Helps Preoperatively Predict Clinically Significant Cancers. , 2016, Radiology.

[18]  Osamu Ukimura,et al.  A Randomized Controlled Trial To Assess and Compare the Outcomes of Two-core Prostate Biopsy Guided by Fused Magnetic Resonance and Transrectal Ultrasound Images and Traditional 12-core Systematic Biopsy. , 2016, European urology.

[19]  D. Margolis,et al.  PI-RADS Prostate Imaging - Reporting and Data System: 2015, Version 2. , 2016, European urology.

[20]  H. Hricak,et al.  Updated prostate imaging reporting and data system (PIRADS v2) recommendations for the detection of clinically significant prostate cancer using multiparametric MRI: critical evaluation using whole-mount pathology as standard of reference , 2016, European Radiology.

[21]  P. Choyke,et al.  Comparison of Multiparametric MRI Scoring Systems and the Impact on Cancer Detection in Patients Undergoing MR US Fusion Guided Prostate Biopsies , 2015, PloS one.

[22]  Baris Turkbey,et al.  Prostate Cancer: Interobserver Agreement and Accuracy with the Revised Prostate Imaging Reporting and Data System at Multiparametric MR Imaging. , 2015, Radiology.

[23]  Baris Turkbey,et al.  Comparison of MR/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer. , 2015, JAMA.

[24]  C. Catalano,et al.  Multiparametric magnetic resonance imaging vs. standard care in men being evaluated for prostate cancer: a randomized study. , 2015, Urologic oncology.

[25]  M. Stifelman,et al.  A prospective, blinded comparison of magnetic resonance (MR) imaging-ultrasound fusion and visual estimation in the performance of MR-targeted prostate biopsy: the PROFUS trial. , 2014, European urology.

[26]  Thomas Hambrock,et al.  Prostate cancer: multiparametric MR imaging for detection, localization, and staging. , 2011, Radiology.